Biopharma Career Opportunities 

Our work can advance the development of new therapeutic options to help transform treatment plans for cancer patients who need them. The Biopharma team at Foundation Medicine works directly with our partners to help accelerate drug development and build strong collaborations that give millions of patients access to more personalized medicines.

With your help, we can offer access to insights and answers that can change even more lives.

Person, Face, Suit, Clothing, Overcoat, Coat, Man, Wood, Beard, Blazer

 

Sanket Agrawal, MPH, MBA, Chief Biopharma Business Officer

Sanket Agrawal joined Foundation Medicine in July of 2021 as Chief Biopharma Business Officer. Mr. Agrawal brings 20 years of diverse leadership experience across life sciences and biopharma including commercial oncology, drug development and commercialization, portfolio and product strategy, partnering and business development, and organizational transformation. 

Current Open Roles on the Team:

 

Sr Mgr, BioPharma Business Development - EMEA Biopharma 102378 Germany Germany Biopharma About the Job The Senior Manager, Business Development - EMEA is responsible for developing and executing upon a comprehensive strategy in account acquisition, management and growth for FMI’s pharmaceutical and biotechnology partners and prospe...
Suit, Overcoat, Clothing, Coat, Person, Blazer, Jacket, Home Decor, People

Interested in other roles at Foundation Medicine? Search below.

Text, Advertisement, Poster

Learn a bit more about us:

 

Behind The Scenes: Promotional Review

Published on Dec 15, 2022

Foundation Medicine at the 18th Annual Massachusetts Conference For Women

Published on Dec 7, 2022

Foundation Medicine's Inaugural Week of Service

Published on Dec 1, 2022

Fostering a Sense of Belonging at Foundation Medicine

Published on Nov 17, 2022

We Are Proud To Honor Our Veterans: Veterans Day 2022

Published on Nov 10, 2022

Day in the Life: The Importance of Real-World Evidence in Men’s Health Research

Published on Nov 2, 2022